Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Free Cash Flow Generation Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Free Cash Flow Generation Index of -0.27x as of September 2025. Free cash flow of CN¥-2.50 Million represents 0% of operating cash flow (CN¥9.12 Million). See Shenzhen Bioeasy Biotechnology Co. Ltd. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Shenzhen Bioeasy Biotechnology Co. Ltd. Free Cash Flow Generation Index (2016–2025)
Historical FCF Generation Index trend for Shenzhen Bioeasy Biotechnology Co. Ltd. across 9 annual periods. Explore 300942 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2025)
Year-by-year Free Cash Flow Generation Index for Shenzhen Bioeasy Biotechnology Co. Ltd.. For the full company profile including market capitalisation, see market value of Shenzhen Bioeasy Biotechnology Co. Ltd..
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | CN¥20.97 Million | CN¥66.87 Million | CN¥45.90 Million | ▲ +107.7% |
| 2024 | -4.08x | CN¥-139.85 Million | CN¥34.26 Million | CN¥174.10 Million | ▼ -2463.4% |
| 2022 | -0.16x | CN¥-24.29 Million | CN¥152.55 Million | CN¥176.85 Million | ▼ -123.1% |
| 2021 | 0.69x | CN¥175.92 Million | CN¥255.42 Million | CN¥79.51 Million | ▲ +330.7% |
| 2020 | -0.30x | CN¥-19.04 Million | CN¥63.79 Million | CN¥82.84 Million | ▼ -149.0% |
| 2019 | 0.61x | CN¥40.95 Million | CN¥67.24 Million | CN¥26.29 Million | ▼ -25.6% |
| 2018 | 0.82x | CN¥47.40 Million | CN¥57.93 Million | CN¥10.53 Million | ▲ +51.1% |
| 2017 | 0.54x | CN¥12.79 Million | CN¥23.60 Million | CN¥10.82 Million | ▼ -27.9% |
| 2016 | 0.75x | CN¥27.29 Million | CN¥36.31 Million | CN¥9.03 Million | — |